作者: Ursula-Henrike Wienhues-Thelen , Serge Masson , Roberto Latini , Dirk Block , Christian Zaugg
DOI:
关键词:
摘要: The present invention relates to a method for assessing whether subject shall be subjected an imaging based diagnostic assessment. is on the determination of amount(s) cardiac Troponin and/or Fibroblast Growth Factor 23 (FGF-23) in sample from subject, and comparison the, thus, determined with reference amount (reference amounts). also system performing assessment reagents kits used methods disclosed herein. Moreover, directed predicting risk mortality cardiovascular event. Also encompassed diagnosing early stage LVH having preserved left ventricular ejection.